Using CRISPR/Cas9 technology to delete IL30 in PC cells led to the suppression of these oncogenes and the upregulation of the tumor suppressor SOCS3, significantly inhibiting tumor growth and metastasis. This evidence concerns the gene SOCS3 and neoplasm.